"Icon Cancer Centre Southport offers a full range of cancer treatments and blood disorder treatments. Treatment options include chemotherapy, immunotherapy, targeted therapies and treatment for blood disorders. Icon has access to scalp cooling systems, clinical trials, pharmacy, pathology and allied health services. There is no wait list, ensuring patients receive immediate access to consultation and treatment. The centre has a team of caring medical oncologists, haematologists, oncology nurses and administrative staff. Free on-site parking is available on Level 4 of Premion Place with entry off White Street."

During the past decade, Icon Cancer Care Southport conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Icon Cancer Care Southport" #1 sponsor was "Pfizer" with 8 trials, followed by "AVEO Pharmaceuticals, Inc." with 1 trials sponsored, "Alphamab (Australia) Co Pty Ltd." with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "LTN PHARMACEUTICALS, INC." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Care Southport" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biodesix, Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Care Southport" are "Prostate Cancer" (4 trials), "Cancer of the Prostate" (2 trials), "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials) and "Cutaneous Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Icon Cancer Care Southport" in a lesser frequency.

Most popular intervention types in "Icon Cancer Care Southport" are "Drug" (13 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Enzalutamide" (3 trials), "Palbociclib" (2 trials), "Avelumab" (1 trials) and "Azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Care Southport" are 7 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Icon Cancer Care Southport". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Icon Cancer Care Southport, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Care Southport, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".